Patients with refractory reflux symptoms: What do they have and how should they be managed?
about
Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn.Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors.The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms.Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.Low-Dose Tricyclics for Esophageal Hypersensitivity: Is it all Placebo Effect?Editorial: refractory GERD-good drug, wrong patients?
P2860
Q35998124-535CE4B4-BE16-493C-BD84-6E4DE6267124Q37726655-87C2EB5A-4CC5-4B4D-84AB-194EF42ADFCAQ38880408-D9703BB0-31DE-4360-9A20-0133EDA49B61Q39418643-0E392208-6C2C-4BD7-96BC-0C984E97A164Q42364784-90E3809D-C390-442E-B09E-EE108B2FEE1DQ48206271-01FAB606-5EC2-4E60-91CD-37AD37FCD50FQ50141250-59D97C3A-4592-45D2-BA6D-E252ADFB8BC6Q52614686-8AF8D2DA-E1EE-44D2-BD4C-689DF82ED64CQ52661254-37CCF15F-FD80-40C0-A6D4-E375F3CFFE48Q53633649-F0AA0AB9-8C60-40AE-A08A-7342336F448CQ54343643-3154CC5A-5C65-4D0A-BE3F-EC092852FF54
P2860
Patients with refractory reflux symptoms: What do they have and how should they be managed?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Patients with refractory reflu ...... nd how should they be managed?
@en
type
label
Patients with refractory reflu ...... nd how should they be managed?
@en
prefLabel
Patients with refractory reflu ...... nd how should they be managed?
@en
P2093
P2860
P356
P1476
Patients with refractory reflu ...... nd how should they be managed?
@en
P2093
J E Pandolfino
P J Kahrilas
P2860
P304
P356
10.1111/NMO.12644
P577
2015-09-01T00:00:00Z